Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers

Journal of the National Cancer Institute

Volumn 109, Issue 5, 2017, Pages

  Lee, Yi Chia ^a,b   Chen, Sam Li Sheng ^c   Yen, Amy Ming Fang ^c   Chiu, Sherry Yueh Hsia ^d   Fann, Jean Ching Yuan ^e   Chuang, Shu Lin ^b,h   Chiang, Tsung Hsien ^a,f   Chou, Chu Kuang ^a,g   Chiu, Han Mo ^a,b   Wu, Ming Shiang ^a   Wu, Chien Yuan ^h   Chia, Shu Li ^b,h   Chiou, Shu Ti ^h,i   Chen, Hsiu Hsi ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e KAINAN UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^h Ministry of Health and Welfare   (Taiwan)

ⁱ NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; ASCENDING COLON; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DESCENDING COLON; FECES; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; MALE; MIDDLE AGED; PATIENT REFERRAL; PRIORITY JOURNAL; SEX DIFFERENCE; TAIWANESE; CANCER STAGING; CHEMISTRY; COLON; COLORECTAL NEOPLASMS; INCIDENCE; MORTALITY; OCCULT BLOOD; PATHOLOGY; PATIENT COMPLIANCE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TAIWAN;

AGED; COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; FECES; FEMALE; HEMOGLOBINS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; OCCULT BLOOD; PATIENT COMPLIANCE; RISK FACTORS; TAIWAN;

EID: 85021380195     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djw269     Document Type: Article

References (48)

1. Bosman FT. Colorectal cancer. In: BW Stewart, CP Wild, eds. World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer; 2014:392-402.
2. Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369(12):1106-1114.
3. Chiang TH, Chuang SL, Chen SL, et al. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Gastroenterology. 2014;147(6): 1317-1326.
4. Zorzi M, Fedeli U, Schievano E, et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut. 2015; 64(5):784-790.
5. Chiu HM, Chen SL, Yen AM, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from one million Taiwanese screening program. Cancer. 2015;121(18):3221-3229.
6. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366(25): 2345-2357.
7. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial. Lancet. 2010;375(9726):1624-1633.
8. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369(12):1095-1105.
9. Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer. Ann Intern Med. 2014;160(3):171-181.
10. Allison JE, Fraser CG, Halloran SP, et al. Population screening for colorectal cancer means getting FIT: The past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver. 2014;8(2):117-130.
11. Steele RJ, McClements PL, Libby G, et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut. 2009;58(4):530-535.
12. Zorzi M, Fedato C, Grazzini G, et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut. 2011;60(7):944-949.
13. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135(1):82-90.
14. Guittet L, Bouvier V, Mariotte N, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut. 2007;56(2):210-214.
15. Zubero MB, Arana-Arri E, Pijoan JI, et al. Population-based colorectal cancer screening: Comparison of two fecal occult blood test. Front Pharmacol. 2014;4:175.
16. Major D, Bryant H, Delaney M, et al. Colorectal cancer screening in Canada: Results from the first round of screening for five provincial programs. Curr Oncol. 2013;20(5):252-257.
17. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150(1):1-8.
18. Kahi CJ, Imperiale TF, Juliar BE, et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009;7(7): 770-775.
19. Brenner H, Chang-Claude J, Seiler CM, et al. Protection from colorectal cancer after colonoscopy: A population-based, case-control study. Ann Intern Med. 2011;154(1):22-30.
20. Doubeni CA, Weinmann S, Adams K, et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: A nested case-control study. Ann Intern Med. 2013;158(5 Pt 1):312-320.
21. Ransohoff DF. How much does colonoscopy reduce colon cancer mortality? Ann Intern Med. 2009;150(1):50-52.
22. Rondagh EJ, Bouwens MW, Riedl RG, et al. Endoscopic appearance of proximal colorectal neoplasms and potential implications for colonoscopy in cancer prevention. Gastrointest Endosc. 2012;75(6):1218-1225.
23. Chen LS, Yen AM, Chiu SY, et al. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol. 2011;12(6):551-558.
24. Auge JM, Pellise M, Escudero JM, et al. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program. Gastroenterology. 2014;147(3):628-636.
25. Yen AM, Chen SL, Chiu SY, et al. A new insight into fecal hemoglobin concentration-dependent predictor for colorectal neoplasia. Int J Cancer. 2014; 135(5):1203-1212.
26. Chen LS, Yen AM, Fraser CG, et al. Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death. BMJ Open. 2013;3(11): e003740.
27. Chen LS, Liao CS, Chang SH, et al. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for populationbased colorectal cancer screening (KCIS 16). J Med Screen. 2007;14(4):191-199.
28. Bosman FT, Carneiro F, Hruban RH, et al., eds. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC; 2010.
29. Lieberman DA, Rex DK, Winawer SJ, et al. United States Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143(3):844-857.
30. Chiang CJ, Chen YC, Chen CJ, et al. Taiwan Cancer Registry Task Force. Cancer trends in Taiwan. Jpn J Clin Oncol. 2010;40(10):897-904.
31. AJCC Edge SB, Byrd DR, Carducci MA, et al., eds. American Joint Committee on Cancer (AJCC) Cancer Staging Manual. 7th ed. New York: Springer; 2009.
32. Socioeconomic Status Database. Department of Statistics, Ministry of the Interior, Taiwan. Available at: http://210.65.89.57/STAT/Web/Portal/STAT-PortalHome.aspx Accessed August 6, 2016.
33. Walter SD, Stitt LW. Evaluating the survival of cancer cases detected by screening. Stat Med. 1987;6(8):885-900.
34. Chen LS, Yen AM, Duffy SW, et al. Computer-aided system of evaluation for population-based all-in-one service screening (CASE-PASS): Fromstudy design to outcome analysis with bias adjustment. Ann Epidemiol. 2010;20(10):786-796.
35. Chen THH, Yen MF, Lai MS, et al. Evaluation of a selective screening for colorectal carcinoma: The Taiwan Mulitcenter Cancer Screening (TAMCAS) Project. Cancer. 1999;86(7):1116-1128.
36. Kaminski MF, Bretthauer M, Zauber AG, et al. The NordICC Study: Rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy. 2012;44(7):695-702.
37. Quintero E, Castells A, Bujanda L, et al. COLONPREV Study Investigators. Colonoscopy vs fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366(8):697-706.
38. Dominitz JA, Robertson DJ. Colonoscopy Vs Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM). Available at: https://clinicaltrials.gov/ct2/show/NCT01239082 Accessed February 20, 2016.
39. Kahi CJ, Imperiale TF, Juliar BE, et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009;7(7): 770-775.
40. Manser CN, Bachmann LM, Brunner J, et al. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: A closed cohort study. Gastrointest Endosc. 2012;76(1):110-117.
41. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: Systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348:g2467.
42. Kahi CJ, Myers L, Pohl H, et al. Association of colonoscopy and colorectal cancer mortality in the veterans affairs system. Gastroenterology. 2016;150:S450, abstract inDDW 2016.
43. Kronborg O, Jørgensen OD, Fenger C, et al. Randomized study of biennial screening with a faecal occult blood test: Results after nine screening rounds. Scand J Gastroenterol. 2004;39(9):846-851.
44. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg. 2008; 95(8):1029-1036.
45. Scholefield JH, Moss SM, Mangham CM, et al. Nottingham trial of faecal occult blood testing for colorectal cancer: A 20-year follow-up. Gut. 2012;61(7): 1036-1040.
46. Heresbach D, Manfredi S, D'halluin PN, et al. Review in depth and metaanalysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol. 2006;18(4):427-433.
47. Chiang TH, Lee YC, Tu CH, et al. Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract. CMAJ. 2011;183(13):1474-1481.
48. Chiu SY, Chuang SL, Chen SL, et al. Fecal hemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: Analysis of Taiwanese nationwide colorectal cancer screening program. Gut. 2015; in press.